Sai Life Sciences IPO allotment status can be checked on the BSE website or Kfin Technologies website. The IPO received a 10x subscription and is expected to list on December 18 with a grey market premium of Rs 61. Proceeds will be used to repay debt and for corporate purposes. The company offers drug discovery and manufacturing services.
